Literature DB >> 16997517

In vitro study of polyoxyethylene alkyl ether niosomes for delivery of insulin.

Abbas Pardakhty1, Jaleh Varshosaz, Abdolhossein Rouholamini.   

Abstract

In this study, niosomes of polyoxyethylene alkyl ethers (Brij) were prepared for encapsulation of insulin by film hydration method. Without cholesterol, brij 35 and brij 58 did not form niosomes, apparently because of relatively large polar head groups in comparison with their alkyl chains. The size of vesicles depended on the cholesterol content, charge incorporation or hydrophilicity of surfactants. Entrapment of insulin in bilayer structure of niosomes protected it against proteolytic activity of alpha-chymotrypsin, trypsin and pepsin in vitro. The maximum protection activity was seen in brij 92/cholesterol (7:3 molar ratios) in which only 26.3+/-3.98% of entrapped insulin was released during 24h in simulated intestinal fluid (SIF). The kinetic of drug release for most formulations could be best described by Baker and Lonsdale equation indicating diffusion based delivery mechanism. These results indicate that niosomes could be developed as sustained release oral dosage forms for delivery of peptides and proteins such as insulin.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16997517     DOI: 10.1016/j.ijpharm.2006.08.002

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  29 in total

1.  Development and optimization of novel controlled-release pioglitazone provesicular powders using 3² factorial design.

Authors:  Marwa H Shukr; Nadia A Eltablawy
Journal:  Drug Deliv Transl Res       Date:  2015-02       Impact factor: 4.617

Review 2.  Nanocarrier fabrication and macromolecule drug delivery: challenges and opportunities.

Authors:  Vibhuti Agrahari; Vivek Agrahari; Ashim K Mitra
Journal:  Ther Deliv       Date:  2016

3.  Nonionic surfactant vesicles for delivery of RNAi therapeutics.

Authors:  Orapan Paecharoenchai; Lesheng Teng; Bryant C Yung; Lirong Teng; Praneet Opanasopit; Robert J Lee
Journal:  Nanomedicine (Lond)       Date:  2013-11       Impact factor: 5.307

4.  Polysorbate cationic synthetic vesicle for gene delivery.

Authors:  Yongzhuo Huang; Yuefeng Rao; Jinliang Chen; Victor C Yang; Wenquan Liang
Journal:  J Biomed Mater Res A       Date:  2011-01-04       Impact factor: 4.396

5.  pH-sensitive pHLIP® coated niosomes.

Authors:  Mohan C Pereira; Monica Pianella; Da Wei; Anna Moshnikova; Carlotta Marianecci; Maria Carafa; Oleg A Andreev; Yana K Reshetnyak
Journal:  Mol Membr Biol       Date:  2017-08-09       Impact factor: 2.857

6.  Paclitaxel incorporated exosomes derived from glioblastoma cells: comparative study of two loading techniques.

Authors:  Soodeh Salarpour; Hamid Forootanfar; Mostafa Pournamdari; Meysam Ahmadi-Zeidabadi; Marzie Esmaeeli; Abbas Pardakhty
Journal:  Daru       Date:  2019-07-17       Impact factor: 3.117

7.  Comparative study on the effects of some polyoxyethylene alkyl ether and sorbitan fatty acid ester surfactants on the performance of transdermal carvedilol proniosomal gel using experimental design.

Authors:  Ahmed A Aboelwafa; Doaa Ahmed El-Setouhy; Aliaa Nabil Elmeshad
Journal:  AAPS PharmSciTech       Date:  2010-11-10       Impact factor: 3.246

8.  PEGylated synthetic surfactant vesicles (Niosomes): novel carriers for oligonucleotides.

Authors:  Yongzhuo Huang; Jinliang Chen; Xiaojin Chen; Jianqing Gao; Wenquan Liang
Journal:  J Mater Sci Mater Med       Date:  2007-07-10       Impact factor: 3.896

9.  Ocular ketoconazole-loaded proniosomal gels: formulation, ex vivo corneal permeation and in vivo studies.

Authors:  Ghada A Abdelbary; Maha M Amin; Mohamed Y Zakaria
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

10.  In vitro and in vivo investigation for optimization of niosomal ability for sustainment and bioavailability enhancement of diltiazem after nasal administration.

Authors:  H O Ammar; M Haider; M Ibrahim; N M El Hoffy
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.